Background/Objectives: Iron deficiency anemia (IDA) and stunting are prevalent global health issues, particularly in developing countries, where previous studies have suggested a potential relationship between them. This systematic review aims to analyze the relationship between iron deficiency anemia and stunting in pediatric populations in developing countries. Methods: Literature searches were conducted on PubMed, EMBASE, Cochrane Library, and EBSCO Host. The primary outcome was the association between IDA and stunting. Risk of bias was assessed using the Newcastle–Ottawa Scale (NOS) for cohort studies and the Effective Public Health Practice Project (EPHPP) for other observational studies. Meta-analysis was performed with a random-effects model and heterogeneity assessment. A Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) assessment was performed to determine the certainty and importance of the study. Results: Out of 19,095 articles, 15 studies were included in the systematic review, and 4 studies were included in the meta-analysis, encompassing 21,936 subjects aged 0 to 12 years. IDA prevalence ranged from 3.6 to 58.8%, while stunting prevalence varied from 6.6 to 44.5%. Nine articles supported a significant relationship between IDA and stunting, revealing that stunted children had a 1.31–6.785 times higher risk of developing IDA. The odds ratio of children with IDA to be stunted was 2.27 (95% CI = 1.30–3.95). All studies exhibited a moderate risk of bias. GRADE assessment suggested that the evidence’s certainty is low but important. Conclusions: The high IDA prevalence in developing countries, including Indonesia, is associated with stunting in children, suggesting a synergistic relationship.
Introduction The increasing popularity of cannabinoids for treating numerous neurological disorders has been reported in various countries. Although it reduces tetrahydrocannabinol psychoactivity, it helps patients tolerate higher doses and complements the anti-spasmodic effects of tetrahydrocannabinol. One of the most important potential of cannabinoids are related to its potential to help children with cerebral palsy, a contributor of lifelong disability. Therefore, this systematic review aimed to assess the efficacy and safety of medical cannabinoids in children with cerebral palsy. Methods
20 February 2023 in Media Dermato-Venereologica Indonesiana
Kekambuhan kusta didefinisikan sebagai munculnya kembali tanda dan gejala kusta setelah pasien menyelesaikan Multidrug Therapy (MDT) secara adekuat. Indonesia menjadi negara ketiga penyumbang kasus kekambuhan kusta terbanyak, yaitu 284 kasus pada tahun 2018. Faktor yang berperan dalam terjadinya kekambuhan adalah kuman persisters, terapi inadekuat, resistensi obat, terapi yang tidak teratur, monoterapi dapson, indeks bakteriologis awal yang tinggi, jumlah lesi kulit dan saraf yang banyak, hasil tes lepromin negatif, pemberian terapi antireaksi, infeksi human immunodeficiency virus (HIV), dan kehamilan. Diagnosis kekambuhan dapat ditegakkan dengan kriteria klinis, bakteriologis, dan terapeutik, serta kriteria histopatologi dan serologis, apabila memungkinkan. Dengan kriteria tersebut, diharapkan lebih mudah membedakan kekambuhan dengan reaksi, resistensi, reaktivasi, dan reinfeksi. Tata laksana kekambuhan utamanya adalah pemberian kembali MDT sesuai tipe kekambuhan kusta namun terapi perlu dimodifikasi apabila terjadi resistensi obat. Hal yang penting diperhatikan saat pengobatan kekambuhan adalah tipe kusta, riwayat terapi sebelumnya, dan kemungkinan resistensi obat. Dengan pemahaman dan penegakan diagnosis yang tepat, diharapkan terapi dapat segera diberikan sehingga mencegah kecacatan dan transmisi infeksi.